Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

EGM Statement

30 Aug 2005 11:08

Stanelco PLC30 August 2005 30 August 2005 Stanelco PLC ("Stanelco" or "the Company") EGM Statement Stanelco PLC is pleased to announce that all the resolutions at the Company'sEGM held at 10.00a.m. this morning were duly passed. The acquisition of BiotecHoldings GmbH ("Biotec") will therefore be completed shortly. As a result, the previously announced conditional sale of a 50% interest inBiotec to SP Metal S.A. ("SP Metal") will also shortly become effective and theconsideration received by Stanelco will be used to fund 50% of the Biotecacquisition. Under the joint venture more of Biotec's considerable IntellectualProperty portfolio will be commercialised. Biotec have received a conditionalcommitment from SP Metal for an annual purchase of approximately 10,000 metrictonnes of Biotec's biodegradable plastic pellet worth in excess of €20m peryear. Stanelco and SP Metal had initially agreed to increase Biotec's productioncapacity of biodegradable pellets to at least 12,000 metric tonnes within ninemonths via a joint investment programme of up to €4.5m. However due to furtherrecent improvements in both the production procedures and the ability to processthe materials, a capacity of 24,000 tonnes for an investment of €2m is nowenvisaged within the same period. In an earlier announcement today, NatureWorks LLC, a wholly owned subsidiary ofCargill Inc has agreed the supply of the major component of Biotec's Starpolmaterials which will make Biotec's products price competitive with a number ofmaterials currently used in the target market segments. Business update GREENSEALTM Commercial trials with ASDA Stores Limited ("ASDA") suppliers have beensuccessfully completed and the 12 month exclusivity period with ASDA, who havecommitted to converting several hundred machines in the period, commenced on28th July 2005. To date, two contracts orders have been received from dedicatedASDA suppliers covering 5 machines in total. Martin Wagner, recently recruited from Asda, as Commercial Director of StanelcoRF Technologies Limited, is now leading the drive for roll out and furthercommercialisation in the UK. In addition the Company has reached commercial agreement with G Mondini Spa, aworld leading manufacturer of tray lidding machines, to jointly develop apurpose built radio frequency ("RF") tray lidding machine using Stanelco'sGREENSEALTM technology. This is an important development as it should allowStanelco to supply its technology to food packers as part of new originalequipment manufacter ("OEM") machines as an alternative to retrofitting existingmachines in operation. This will greatly speed up the acceptance of theGREENSEALTM technology as an industry standard within the packaging industry. We remain confident of being able to announce a number of additionaldevelopments in relation to the commercialisation of this technology in thecoming months. Frogpack The commercialisation of Frogpack, our simple, new, patented, lightweight,highly impact resistant, low cost and greener packaging format is developingwell with orders received from existing distributors and agreements beingnegotiated with further distributors in North America. Philip Lovegrove, Chairman of Stanelco said: "I am pleased with the continued progress at the company. We have a strongmanagement team with some extremely exciting opportunities ahead of us. Thepassing of all resolutions at today's EGM, allowing us to complete the Biotecacquisition will enable further progress towards our aim of becoming one of theworld's leading exponents of viable, alternative, environmentally responsiblepackaging methods." Ends For further information please contact:Ian Balchin, Chief ExecutiveStanelco PLCTel: +44 (0)2380 867 100 Jonathon Brill/Billy CleggFinancial DynamicsTel: +44 (0)20 7831 3113 About Stanelco plc The Stanelco Group of companies (the Group) has brought together expertise inradio frequency (RF) technology, RF applications and biodegradable materialsciences to create a revolutionary range of packaging technologies. Stanelco's philosophy is that new products and processes must offer solutionsand applications which: • give higher added value, • are greener, more environmentally sustainable than those they replace • and have protectable intellectual property rights. Stanelco will develop the products and processes to a demonstration stage andthen work with partners in order to reach the markets; and under thesecircumstances Stanelco will usually seek to license its technology. Stanelcoinvests considerable time and resources in ensuring its technologies areprotected via layers of patents wherever possible. In this way Stanelco believes it can minimise commercial risk and preserve thehighest value for shareholders. The products offering the prospect of near term revenue generation are beinggiven priority over the Group's resources. Stanelco was founded in 1953 and is a world leader in the development of radiofrequency technologies for processing polymers for edible and packagingapplications and the design and manufacture of optical fibre technology,induction heating and dielectric welding equipment. Stanelco's Currentdevelopments include GREENSEAL Food tray lidding technology, STARPOL (starch /pva blended material), FrogPack high impact low cost packaging format,CradleWrap range of biodegradable air cushion packaging, Soluble tape, 100%water-soluble films and adhesives, Biodegradable Airbag (void fill) packaging,water-soluble detergent capsules, edible sachets and waste packing. GREENSEAL, STARPOL, Frog Pack and CradleWrap are all trademarks of the Stanelcoplc group. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.